Managing Tardive Dyskinesia: Clinical Pointers

Psychopharmacology and Psychiatry Updates

English - December 14, 2020 17:00 - 8 minutes - 7.51 MB - ★★★★★ - 232 ratings
Medicine Health & Fitness Science mentalhealth psychiatry psychopharmacology Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Lithium: How to Manage Weight Gain and GI Side Effects

Next Episode: Top 10 Drug Combinations in Major Depressive Disorder: Interview with Dr. Michael Thase PART 1

Today's episode is about the management of tardive dyskinesia.

Here are some questions we cover in this episode:

What is the best way to approach tardive dyskinesia? This episode will discuss an algorithm with levels of evidence for each treatment option. What is the evidence level for second-generation VMAT-2 inhibitors, such as deutetrabenazine and valbenazine? Is there evidence for prescribing anticholinergics in tardive dyskinesia? Should you use them? What options do you have if a VMAT inhibitor is not effective or well tolerated?

Faculty: Greg Pontone, M.D.

Learn more about Premium Membership here Earn 1.25 CMEs: "Drug-Induced Movement Disorders: The Clinical Essentials" Treating Tardive Dyskinesia: A Clinical Conundrum and New Approaches